It's the Viread (tenofovir) you know and love -- only better!
Viread, one of the most widely used HIV drugs in the U.S., is a component of the once-a-day pills Atripla and Truvada (tenofovir/FTC). It's been around a long time -- since 2001, matter of fact. And although it's generally viewed as one of our "friendlier" HIV medications in terms of side effects, it's far from perfect: Over the years, it's been associated with a number of health issues, particularly bone loss and kidney damage, that can make it a challenge to use for people who are already predisposed to those problems.
This year, we learned about encouraging data regarding a new-and-improved form of Viread called tenofovir alafenamide fumarate, or TAF. Doctors have been buzzing about this drug for a while, but studies in 2013 have re-introduced TAF into the conversation, as their data are beginning to show just how much better its side-effect profile appears to be compared to the "old" Viread.
Read the full story >>